The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Chernousov A.F.

Department of faculty surgery №1, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia

Khorobrykh T.V.

Department of faculty surgery №1, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia

Vychuzhanin D.V.

Department of Preventive and Emergency Cardiology, Sechenov First Moscow State Medical University, Moscow

Kharlov N.S.

Department of Preventive and Emergency Cardiology, Sechenov First Moscow State Medical University, Moscow

Nurutdinov R.

University's Clinical Hospital №1, Burdenko Clinic of Faculty Surgery, Sechenov First Moscow State Medical University of Ministry of Health, Moscow, Russia

Subcutaneous port systems with intraperitoneal catheter «BBraun» in combined treatment of advanced stomach cancer

Authors:

Chernousov A.F., Khorobrykh T.V., Vychuzhanin D.V., Kharlov N.S., Nurutdinov R.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2016;(7): 67‑71

Read: 1885 times


To cite this article:

Chernousov AF, Khorobrykh TV, Vychuzhanin DV, Kharlov NS, Nurutdinov R. Subcutaneous port systems with intraperitoneal catheter «BBraun» in combined treatment of advanced stomach cancer. Pirogov Russian Journal of Surgery. 2016;(7):67‑71. (In Russ.)
https://doi.org/10.17116/hirurgia2016767-71

Recommended articles:
Small cell carcinoma of the paro­tid gland. P.A. Herzen Journal of Onco­logy. 2025;(4):69-74

References:

  1. Kaprin А.V., Starinskij V.V., Petrova G.V. Zlokachestvennye zabolevaniya v Rossii v 2013 g. (zabolevaemost' I smertnost'). MNIOI im. P.А. Gertsena - filial FGBU «FMITS im. P.А. Gertsena» Minzdrava Rossii. 2015;4-13. (in Russian)
  2. Ishigami S, Uenosono Y, Arigami T, Yanagita S, Okumura H, Uchikado Y, Kita Y, Kurahara H, Kijima Y, Nakajo A, Maemura K, Natsugoe S. Clinical utility of perioperative staging laparoscopy for advanced gastric cancer. World J Surg Oncol. 2014;12:350. doi: 10.1186/1477-7819-12-350
  3. Peng YF, Imano M, Itoh T, Satoh T, Chiba Y, Imamoto H, Tsubaki M, Nishida S, Yasuda T, Furukawa H. A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S-1 plus intravenous paclitaxel for serosa- positive gastric cancer. J Surg Oncol. 2015;111(8):1041-1046. doi: 10.1002/jso.23928
  4. Nered S.N., Klimenkov А.А., Stilidi I.S., Perevoshhikov А.G., Gubina G.I., KHirurgicheskoe i kombinirovannoe lechenie bol'nykh rakom zheludka s vysokim riskom implantatsionnogo metastazirovaniya, Zasedanie Moskovskogo Onkologicheskogo Obshhestva №529; tema Intraoperatsionnaya khimioterapiya: otsenka ehffektivnosti vozdej stviya na intraperitoneal'nye metastazy. RONTS im. N.N. Blokhina. 2008.(in Russian)
  5. Sugarbaker PH, Bijelic L. Adjuvant bidirectional chemotherapy using an intraperitoneal port. Gastroenterol Res Pract. 2012;752643. doi: 10.1155/2012/752643
  6. Radulescu C, Tufeanu D, Mintioan C, Crstici D, Traila N. Intraperitoneal chemotherapy for advanced gastric cancer. TMJ. 2008;59:49- 55.
  7. Аbdurakhmanov B.А., Gantsev SH.KH., Kulakeev O.K., Features of peritoneal port-systems in the treatment of diuretic-resistant ascites in patients with liver cirrhosis. KHirurgiya. 2010;4:30-33. (in Russian)
  8. Keen A, Fitzgerald D, Bryant A, Dickinson HO. Management of drainage for malignant ascites in gynaecological cancer. Cochrane Database Syst Rev. 2010;1:CD007794. Doi: 10.1002/14651858
  9. Markman M, Walker JL. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment. J Clin Oncol. 2006;24(6):988-994. doi:10.1200/jco.2005.05.2456
  10. Henretta MS, Anderson CL, Angle JF, Duska LR. It & apos; s not just for laparoscopy anymore: use of insufflation under ultrasound and fluoroscopic guidance by Interventional Radiologists for percutaneous placement of intraperitoneal chemotherapy catheters. Gynecol Oncol. 2011;123(2):342-345. doi: 10.1016/j.ygyno.2011.07.031
  11. Makhija S, Leitao M, Sabbatini P, Bellin N, Almadrones L, Leon L, Spriggs DR, Barakat R. Complications associated with intraperitoneal chemotherapy catheters. Gynecol Oncol. 2001;81(1):77-81. doi: 10.1006/gyno.2000.6108
  12. Walker JL, Armstrong DK, Huang HQ, Fowler J, Webster K, Burger RA, Clarke-Pearson D. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study. Gynecol Oncol. 2006;100(1):27-32. doi: 10.1016/j.ygyno.2005.11.013
  13. Topuz E, Salihoglu Y, Aydiner A, Saip P, Tas F, Sozen T, Berkman S, Bengisu E. Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer. J Surg Oncol. 2000;74(3):223-226. doi: 10.1002/1096- 9098(200007)74:3<223::AID-JSO14>3.0.CO;2-Q
  14. Helm CW. Ports and complications for intraperitoneal chemotherapy delivery. BJOG. 2012;119(2):150-159. doi: 10.1111/j.1471-0528.2011.03179.x
  15. Emoto S, Ishigami H, Hidemura A, Yamaguchi H, Yamashita H, Kitayama J, Watanabe T. Complications and management of an implanted intraperitoneal access port system for intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. Jpn J Clin Oncol. 2012;42(11):1013-1019. doi: 10.1093/jjco/hys129
  16. Arts HJ, Willemse PH, Tinga DJ, De Vries EG, Van Der Zee AG. Laparoscopic placement of PAP catheters for intraperitoneal chemotherapy in ovarian carcinoma. Gynecol Oncol. 1998;69(1):32-35. doi: 10.1006/gyno.1998.4968
  17. Berry E, Matthews KS, Singh DK, Buttin BM, Lurain JR, Alvarez RD, Schink J. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer. Gynecol Oncol. 2009;113(1):63-67. doi: 10.1016/j.ygyno.2008.12.035
  18. Jaka RC, Somashekhar SP, Zaveri SS, Ahmed Z, Ashwin KR. Intraperitoneal chemotherapy for epithelial ovarian cancer - single center experience. Indian J Surg Oncol. 2012;3(3):262-266. doi: 10.1007/s13193-012-0166-y
  19. Janco JM, Hacker MR, Konstantinopoulos PA, Cannistra SA, Awtrey CS. Laparoscopic intraperitoneal port placement for optimally cytoreduced advanced ovarian cancer. J Minim Invasive Gynecol. 2011;18(5):629-633. doi: 10.1016/j.jmig.2011.06.005
  20. Kinoshita J, Fushida S, Tsukada T, Oyama K, Watanabe T, Okamoto K, Makino I, Nakamura K, Hayashi H, Nakagawara H, Miyashita T, Tajima H, Takamura H, Ninomiya I, Kitagawa H, Fujimura T, Ohta T. Colonic stenosis caused by infection of an intraperitoneal access port system: a rare complication of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. World J Surg Oncol. 2014;12:177. doi: 10.1186/1477-7819-12-177

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.